Heartflow (HTFL) Revenue & Revenue Breakdown
Heartflow Revenue Highlights
Latest Revenue (Y)
$125.81M
Latest Revenue (Q)
$46.27M
Heartflow Revenue by Period
Heartflow Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $125.81M | 44.32% |
| 2023-12-31 | $87.17M | - |
Heartflow generated $125.81M in revenue during NA 2024, up 44.32% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Heartflow Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $46.27M | 6.57% |
| 2025-06-30 | $43.42M | 16.72% |
| 2025-03-31 | $37.20M | 19.81% |
| 2024-06-30 | $31.05M | 15.69% |
| 2024-03-31 | $26.84M | - |
Heartflow generated $46.27M in revenue during Q3 2025, up 6.57% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Heartflow Revenue Breakdown
Heartflow Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Sep 25 | Jun 25 |
|---|---|---|
| JAPAN | $1.46M | $1.53M |
| Rest Of Europe | $349.00K | $348.00K |
| UNITED STATES | $42.95M | $39.99M |
Latest
Heartflow's latest quarterly revenue breakdown by geography, as of Sep 25: UNITED STATES (95.95%), JAPAN (3.27%), and Rest Of Europe (0.78%).
Heartflow Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PRGO | Perrigo | $4.37B | $1.04B |
| SGRY | Surgery Partners | $3.11B | $821.50M |
| PRVA | Privia Health Group | $1.74B | $580.42M |
| LIVN | LivaNova | $1.25B | $357.80M |
| ATEC | Alphatec | $424.26M | - |
| ZLAB | Zai Lab | $398.99M | $116.09M |
| LEGN | Legend Biotech | $285.14M | $93.99M |
| TVTX | Travere Therapeutics | $233.18M | $164.86M |
| TARS | Tarsus Pharmaceuticals | $182.95M | $118.70M |
| HTFL | Heartflow | $125.81M | $46.27M |
| IRON | Disc Medicine | - | $7.91M |